Taekjun Lidocaine Visco 2% Solution

Adult dosage

Adults: The maximum single dose for healthy adults should not exceed 4.5 mg of lidocaine hydrochloride per kg of body weight, and the total dosage should not exceed 300 mg (15 mL of this drug). For symptomatic treatment of oral and pharyngeal mucosa irritation or inflammation, a dose of 300 mg (15 mL of this drug) is administered. For oral use, the drug is retained in the mouth before being spat out, while for pharyngeal use, it may be swallowed after retention. It should not be reused within 3 hours.

This drug is an amide-type local anesthetic and should not be used in certain patients. It should not be administered to patients with allergic reactions to this drug or similar medications. Caution is advised for patients with wounds or mucosal damage at the application site. While using this medication, symptoms such as shock, hypotension, facial pallor, irregular heartbeat, or breathing problems may occur; therefore, careful monitoring is required. It can affect the central nervous system, and if symptoms such as tremors or convulsions appear, use should be discontinued immediately, and appropriate treatment should be sought. Various neurological side effects can arise, including drowsiness, anxiety, dizziness, vomiting, headache, confusion, numbness, and respiratory depression, necessitating caution. It may also affect the heart and blood vessels, leading to decreased heart rate, hypotension, and in severe cases, heart attack. Skin rash, swelling, and allergic reactions may occur, so any unusual symptoms should be reported immediately. Emergency measures should be prepared before using it, and to minimize side effects, the patient's condition should be closely monitored, and the minimum necessary dose should be used. When using in the mouth, swallowing may be impaired, increasing the risk of aspiration, so food intake should be avoided for 60 minutes after administration, particularly for children. Caution is also needed as the tongue or oral mucosa may be numbed, leading to unintentional injuries in the mouth. It should be used during pregnancy or in women who may become pregnant only when the benefits of therapy are judged to outweigh the risks, as safety has not been established. During breastfeeding, caution is required since this medication may transfer to breast milk. The solution should be shaken well before use to ensure uniformity. Additionally, this drug contains components that have shown carcinogenic potential in animal studies, so prolonged or excessive use may be harmful to health.

Serious side effects

• Facial pallor
• respiratory depression
• respiratory arrest
• shock
• hypotension
• irregular pulse
• bradycardia
• low blood pressure
• circulatory collapse
• cardiac arrest

Mild side effects

• Tremors
• convulsions
• drowsiness
• anxiety
• agitation
• numbness
• dizziness
• nausea
• vomiting
• mild headache

This medication should be stored in a tightly closed container to prevent exposure to air and moisture. It is important to maintain storage temperature between 15 to 30 degrees Celsius.

Appearance

Slightly pale yellow transparent viscous solution

Package unit

15 milliliters/pack[X20], 15 milliliters/pack[X30]